OncologyOncology
Charlson Comorbidity Index (CCI)
Predicts 10-year mortality based on a weighted score of 17 comorbid conditions, widely used in oncology and surgery.
Myocardial infarction (history of, not ECG changes alone)
Congestive heart failure
Peripheral vascular disease (including aortic aneurysm ≥6 cm)
Cerebrovascular disease (stroke or TIA)
Dementia
Chronic pulmonary disease (COPD or asthma)
Connective tissue / rheumatologic disease
Peptic ulcer disease
Mild liver disease (without portal hypertension, includes chronic hepatitis)
Diabetes mellitus (without end-organ damage)
Hemiplegia or paraplegia
Moderate/severe renal disease (CKD stage 3–5 or on dialysis)
Diabetes with end-organ damage (retinopathy, neuropathy, or nephropathy)
Any solid tumour / malignancy (non-skin, treated within past 5 years)
Leukaemia (acute or chronic)
Lymphoma (including myeloma)
Moderate/severe liver disease (portal hypertension, varices, or decompensation)
Metastatic solid tumour
AIDS (not just HIV-positive; AIDS-defining illness)
0
CCI Score
Excellent — ~98% 10-year survival
CCI 0: No significant comorbidity. Predicted 10-year survival approximately 98%.
Reference: Charlson ME et al. J Chronic Dis 1987
Medical Disclaimer: This calculator is a clinical decision support tool for qualified healthcare professionals. It does not replace clinical judgement. Always interpret results in the full clinical context. Reference: Charlson ME et al. J Chronic Dis 1987.
More Oncology Calculators
OncologyECOG Performance Status
Classifies a cancer patient's functional status to guide treatment intensity and clinical trial eligibility.
OncologyKarnofsky Performance Scale
Quantifies cancer patient's functional impairment to compare effectiveness of therapies and assess prognosis.
OncologyNottingham Prognostic Index
Combines tumour size, lymph node stage, and histological grade to estimate prognosis in early breast cancer.